Tagged: TRIPS
New Oxfam report: The proliferation of substandard medicines in poor countries is being used by rich countries as an excuse to tighten intellectual property rules, boosting the profits of large pharmaceutical companies while making it harder for poor people to get access to the medicines they need.
The European Union is contradicting world trade rules by putting the interests of big drug companies before the 2 billion people in the world who cannot access essential medicines, according to a new report issued today by Oxfam International and Health Action International Europe.
17 Feb – Pharmaceutical giant GlaxoSmithKline should be congratulated for breaking industry ranks and taking a major step toward helping poor people in developing countries to get better access to medicines, says international agency Oxfam. However GSK’s initiative this week is just the beginning.

